Loading

JSM Biomarkers

Homonymous Hemimacular Ganglion Cell Layer Loss Detectable by SD-OCT: A Biomarker of Retrochiasmal Visual Pathway Lesion

Short Communication | Open Access | Volume 2 | Issue 1

  • 1. Department of Neurology, Institute of Clinical and Experimental Medicine, Linköping University Hospital, Sweden
  • 2. Department of Radiology, Institute of Clinical and Experimental Medicine, Linköping University Hospital, Sweden
  • 3. Department of Radiology, Institute of Clinical and Experimental Medicine, Linköping University Hospital, Sweden
  • 4. Department of Radiology, Institute of Clinical and Experimental Medicine, Linköping University Hospital, Sweden
  • 5. Department of Clinical Neuroscience, Karolinska Institute, Sweden
+ Show More - Show Less
Corresponding Authors
Yu-Min Huang-Link, Department of Neurology, Institute of Clinical and Experimental Medicine, Linköping University Hospital, 581 85 Linköping, Sweden Tel: +46101031414; Fax: 46 10103 4438
ABSTRACT

n the retina, Ganglion Cell Layer (GCL) and their axons Retinal Nerve Fiber Layer (RNFL) representing the first-order neurons of the visual pathway can be affected by retrograde degeneration of the Central Nervous System (CNS) lesions. Thickness of GCL and RNFL can be quantified close to histological level using Spectral-Domain Optical Coherence Tomography (SD-OCT). We report two patients, one with previous ischemic stroke affecting left medial occipital lobe with permanent right homonymous hemianopia, and one with Multiple Sclerosis (MS) and a MS plaque at the right optic radiation but no homonymous hemianopia. Both patients had homonymous hemimacular GCL loss irrespective of visual field defect. Homonymous hemimacular GCL loss is consistent with ipsilateral retrochiasmal visual pathway lesions and represents imaging biomarker of retrochiasmal lesions which can be detected precisely and easily by OCT. This imaging biomarker can be of value in diagnosis, prognosis and clinical trials of developing novel therapies.

KEYWORDS

Macular ganglion cell layer ; Homonymous visual field effect ;Spectral-domain optical coherence tomography ; Retinal nerve fiber layer; Retrograde degeneration ;Retrochiasmal visual pathway ; Biomarker ; Ischemic stroke ; Multiple sclerosis ; Optical coherence tomography; macular ganglion cell layer; retinal nerve fiber layer; retrograde degeneration; visual pathway.

CITATION

 Huang-Link YM, Petré B, Lindehammar H, Al-Hawasi A, Link H (2015) Homonymous Hemimacular Ganglion Cell Layer Loss Detectable by SD-OCT: A Biomarker of Retrochiasmal Visual Pathway Lesion. JSM Biomar 2(1): 1006.

ABBREVIATIONS

CSF: Cerebrospinal Fluid; GCL-IPL: Ganglion Cell Layer—Inner Plexiform Layer; SD-OCT: Spectral-Domain Optical Coherence Tomography; RNFL: Retinal Nerve Fiber Layer; MRI: Magnetic Resonance Imaging; VEP: Visual Evoked Potentials; VF: Visual Field

INTRODUCTION

Optical Coherence Tomography (OCT) using the intensity of back-reflected infrared light provides non-contact, real-time, high-resolution imaging of the retina. Spectral-Domain OCT (SD-OCT) with higher speed and a broader wavelength improves image resolution to a few micrometers and visualizes the retinal microstructure with 10 distinct layers close to histologic level [1]. The first-order neuron of the visual pathway, equal to the Ganglion Cell Layer (GCL) in the macula and their unmyelinated axons in the optic disc, equal to the Retinal Nerve Fiber Layer (RNFL), provide a natural window to study the Central Nervous System (CNS). Thinning of macular GCL and peripapillary RNFL can occur through retrograde trans-synaptic degeneration of second-order neurons in the brain, as detected by magnetic resonance imaging (MRI). The thickness of GCL and RNFL may reflect global CNS damage [2, 3], and they have been suggested as biomarkers of brain atrophy [4].

Lesions of the retrochiasmal visual pathway resulting from stroke [5] are characterized by a homonymous visual field (VF) defect. In contrast, lesions of the visual pathway caused by neuro-inflammation like multiple sclerosis (MS) may not lead to persistent visual field defects [6, 7]. Impaired low-contrast letter acuity [8] and color vision may be present in MS [9]. Irrespective of location and cause of lesion in retrochiasmal visual pathway, and degree of visual dysfunction, SD-OCT can visualize distinct homonymous hemimacular GCL loss which corresponds to ipsilateral lesions behind the chiasm. This unique pattern of GCL loss is a hallmark of primary CNS lesion and CNS damage-related visual disability. Here, we report 2 patients with homonymous hemimacular GCL loss on SD-OCT and lesion in ipsilateral retrochiasmal visual pathway on MRI, in presence or absence of homonymous VF defect.

CASES

Case 1 is a 56-year-old woman who, as a teenager, suffered from toxoplasma chorioret. It was diagnosed by ophthalmoscopy. Her visual acuity had been 4/20 in the left eye and 20/20 in the right eye. At age 20, she suffered from a left hemispheric ischemic stroke with right homonymous hemianopia as sequel. At age 54, she developed a loss of pain and temperature affecting her left arm and leg over a few days. A brain MRI showed an old ischemic lesion of the left medial occipital lobe (Figure 1A). Spinal cord MRI showed one spinal cord lession C3 (Figure 1B), diagnosed as myelitis. Cerebrospinal fluid (CSF) showed slight mononuclear pleocytosis, a normal CSF/serum albumin ratio, no oligoclonal IgG bands and negative serology for viral and bacterial infection. The anti-aquaporin-4 antibody was negative on two occasions, tested 6 months apart. The sensory symptoms disappeared after 6 months without therapy. Follow-up with brain and spinal cord MRI and repeated CSF analysis 1 and 2 years after onset, respectively, showed no new findings on MRI and normal CSF.

Ophthalmological examinations revealed an unchanged optic disk for many years, with a normal fundus in the right eye (Figure C) and retinochoroidal scars in the left macula on ophthalmoscopy (Figure 1D). Intraocular pressure was normal (right 14, left 15 mm Hg). SD-OCT on three occasions during the last 1.5 years showed unchanged nasal hemimacular GCL loss of the right eye (Figure 1E), atrophy of the left macula (Figure 1F), and bilaterally reduced RNFL thickness (Figures 1G and H). Automated Visual Field (VF) with the Humphrey instrument showed right homonymous hemianopia (Figure 1I). Visual Evoked Potentials (VEP) showed normal latency of P100 (positive downwards) bilaterally (100 microseconds), normal amplitude in the right eye (15 microvoltages), and lower amplitude in the left eye (7 microvoltages)

Case 2 is a 34-year-old woman with a 10-year history of multiple sclerosis (MS) without a history of optic neuritis. At age 24, she had vertigo, nausea, ataxia, and diplopia lasting several days. The CSF showed no mononuclear pleocytosis but oligoclonal IgG bands. MRI revealed multiple MS-like plaques in cerebral hemispheres, brain stem, and spinal cord. One lesion was located in the right optic radiation (Figure 2A). The patient has been on interferon-beta therapy. She had four normal childbirths at ages 25, 27, 30, and 33. She had one MS relapse after her first childbirth. During her second and fourth pregnancies, she was treated with intravenous immunoglobulin (IVIg) once per month. The last relapse was 6 months after fourth childbirth, when she had vertigo, nausea, and diplopia lasting several days without a sequel. In

1 Images from 56 years old woman with a history of toxoplasma  chorioretin it is in the left eye and ischemic stroke in the left occipital  lobe. There is a T1-MRI lesion in left medial part of the occipital  lobe (A, arrow), corresponding to right homonymous hemianopia.  A T2 lesion in the spinal cord at C3 (B, arrow) is also seen. Fundus  photography shows normal appearance in the right (C) and inactive  retinochoroid scar in the left eye (D, arrow). Color-coded thickness  map (red = thicker, blue = thinner) from SD-OCT showed loss of nasal  hemimacular ganglion cell + inner plexiform layers (GCL-IPL) in the  right eye (E) and diffuse macular atrophy of the left eye (F). Colorcoded thickness map of optic disc showed slightly reduced retinal  nerve fiber layers (RNFL) in the right eye (G, 76 µm) and moderately  reduced RNFL thickness in the left eye (H, 70 µm). Automated visual  fields (I) showed right homonymous hemianopia, consistent with T1- MRI lesion in the contralateral visual cortex

Figure 1: Images from a 56-year-old woman with a history of toxoplasma chorioretin, it is in the left eye, and an ischemic stroke in the left occipital lobe. There is a T1-MRI lesion in the left medial part of the occipital lobe (A, arrow), corresponding to right homonymous hemianopia. A T2 lesion in the spinal cord at C3 (B, arrow) is also seen. Fundus photography shows a normal appearance in the right eye (C) and an inactive retinochoroid scar in the left eye (D, arrow). A color-coded thickness map (red = thicker, blue = thinner) from SD-OCT showed loss of nasal hemimacular ganglion cells + inner plexiform layers (GCL-IPL) in the right eye (E) and diffuse macular atrophy of the left eye (F). A color-coded thickness map of optic disc showed slightly reduced retinal nerve fiber layers (RNFL) in the right eye (G, 76 µm) and moderately reduced RNFL thickness in the left eye (H, 70 µm). Automated visual fields (I) showed right homonymous hemianopia, consistent with the T1-MRI lesion in the contralateral visual cortex.

In addition, she experienced difficulties with vision and balance in the dark. EDSS was 0. The patient had a high JCV titer, and therapy was switched from IVIg to rituximab 8 months after last childbirth.

Brain MRI during the last relapse revealed gadolinium enhancement of a previous lesion located in the left frontal lobe (Figure 2B). The lesion in the right optic radiation on the MRI remained unchanged. Ophthalmological examinations revealed normal-appearing optic discs (Figures 2C and D). Visual acuity was 20/20 in both eyes. Intraocular pressure and color vision were normal. VEP showed a delayed latency of P100 at 122 microseconds (ms) with normal amplitude in both eyes. SD-OCT on four occasions during the last 1.5 years showed right homonymous hemimacular GCL-IPL loss (Figures 2E and F). Peripapillary RNFL thickness was normal in right eye (Figure 2G) and reduced temporally in left

 Images from 34 years old woman with 10-year history of  MS. A T1-MRI lesion on the right optic radiation (A) is consistent  with ipsilateral homonymous hemimacular loss. There are multiple  MS-like plaques including one enhanced lesion (B, arrow). Fundus  photography showed normal fundus in both eyes (C and D). Colorcoded thickness map (red = thicker, blue = thinner) from SD-OCT  showed hemimacular loss of GCL-IPL (E and F). Color-coded thickness  map of optic disc showed marginally reduced RNFL thickness in the  left eye (G, right 80 µm; and H left 76 µm). Automated Visual Fields  (VF) (I) showed slightly enlarged blind spot in the left and normal in  the right eye.

Figure 2: Images from a 34-year-old woman with a 10-year history of MS. A T1-MRI lesion on the right optic radiation (A) is consistent with ipsilateral homonymous hemimacular loss. There are multiple MS-like plaques, including one enhanced lesion (B, arrow). Fundus photography showed normal fundus in both eyes (C and D). The color-coded thickness map (red = thicker, blue = thinner) from SD-OCT showed hemimacular loss of GCL-IPL (E and F). A color-coded thickness map of optic disc showed marginally reduced RNFL thickness in the left eye (G, right 80 µm; and H, left 76 µm). Automated Visual Fields (VF) (I) showed a slightly enlarged blind spot in the left eye and normal in the right eye.

eye (Figure 2H). VF showed an enlarged central blind spot in the left and normal in the right eye (Figure 2I).

 

RESULTS AND DISCUSSION

We demonstrate that SD-OCT can visualize specific patterns of homonymous hemimacular GCL loss, functioning as an imaging biomarker for primary lesions in the retrochiasmal visual pathway. SD-OCT with a B-scan of 512 x 128 pixels at the macular cube acquires a greater amount of data at a higher speed and better resolution and enables the generation of the microstructure of the retina close to the histological level [2]. Homonymous hemimacular GCL loss detected by SD-OCT corresponds to an ipsilateral lesion behind the chiasm as detected by MRI. Case 1 had an infarction in the occipital lobe. VF defects of homonymous hemianopia persisted, corresponding to the remaining ipsilateral ischemic lesion in visual cortex. Case 2 had MS. Ophthalmologic examination revealed a slightly enlarged blind spot in one eye and moderately delayed VEP latency bilaterally. Other visual functions were intact; fundus findings were unremarkable. Homonymous hemimacular GCL loss on SD-OCT is consistent with ipsilateral MS plaque revealed by MRI in optic radiation.

Homonymous hemianopia has been used as hallmark for retrochiasmal visual pathway damage [10]. Peripheral homonymous hemianopia caused by stroke [11] or surgical lobectomy [12] is consistent with persistent lesions in visual tract and visual cortex. Such lesions can be detected using diffusion-tensor tractography [13]. Selective hemimacular thinning of each eye was also reported in a patient with neuromyelitis optica who had an ipsilateral optic tract lesion confirmed by diffusion-tensor tractography [14]. In a longitudinal study with SD-OCT, we recently observed one MS patient who developed hemimacular GCL-IPL loss over 4 months in relation to MS relapse [15]. One MS plaque was detected in ipsilateral optic radiation by MRI, although the patient had no new visual dysfunction. Additional thinning of hemimacular GCL-IPL was registered in another patient with subclinical progressive MS who had had an ipsilateral optic radiation lesion on MRI for several years [15]. This patient also had unchanged visual dysfunction. In a longitudinal study of ON, we observed GCL-IPL thinning earlier than RNFL thinning and were not affected by optic disc swelling [16]. We believe that hemimacular GCL-IPL loss detected by SD-OCT is a sensitive and specific imaging biomarker for lesions in retrochiasmal visual pathway, even in absence of VF defects.

CONCLUSION

These two cases illustrate existence of retrograde degeneration of visual pathway. Homonymous hemimacular GCL-IPL loss visualized by SD-OCT is consistent with ipsilateral lesions behind chiasm detectable by MRI, irrespective of VF defect. Such selective GCL-IPL loss can thus eventually serve as imaging biomarker to localize visual pathway lesions, monitoring disease progression and prognosis.

ACKNOWLEDGEMENT

The authors gratefully acknowledge financial support from Linköping University and the County Council of Östergötland, Sweden.

Conflict of Interest

The authors declare no conflict of interest. The study was approved by the Ethics Committee Review Board of the University in Linköping, Sweden (reference number 2013/141-31).

REFERENCES

 

  1. Schuman JS. Spectral domain optical coherence tomography for glaucoma (an AOS thesis). Trans Am Ophthalmol Soc. 2008; 106: 426-458.
  2. Dörr J, Wernecke KD, Bock M, Gaede G, Wuerfel JT, Pfueller CF, et al. Association of retinal and macular damage with brain atrophy in multiple sclerosis. PLoS One. 2011; 6: e18132.
  3. Saidha S, Sotirchos ES, Oh J, Syc SB, Seigo MA, Shiee N, et al. Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol. 2013; 70: 34-43.
  4. Gabilondo I, Martínez-Lapiscina EH, Martínez-Heras E, Fraga-Pumar E, Llufriu S, Ortiz S, et al. Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Ann Neurol. 2014; 75: 98-107.
  5. Zhang X, Kedar S, Lynn MJ, Newman NJ, Biousse V. Homonymous hemianopia in stroke. J Neuroophthalmol. 2006; 26: 180-183.
  6. Balcer LJ, Miller DH, Reingold SC, Cohen JA. Vision and vision-related outcome measures in multiple sclerosis. Brain. 2015; 138: 11-27.
  7. Plant GT, Kermode AG, Turano G, Moseley IF, Miller DH, MacManus DG, et al. Symptomatic retrochiasmal lesions in multiple sclerosis: clinical features, visual evoked potentials, and magnetic resonance imaging. Neurology. 1992; 42: 68-76.
  8. Millington RS, Yasuda CL, Jindahra P, Jenkinson M, Barbur JL, Kennard C, et al. Quantifying the pattern of optic tract degeneration in human hemianopia. J Neurol Neurosurg Psychiatry. 2014; 85: 379-386.
  9. Martínez-Lapiscina EH, Ortiz-Pérez S, Fraga-Pumar E, Martínez-Heras E, Gabilondo I, Llufriu S, et al. Colour vision impairment is associated with disease severity in multiple sclerosis. Mult Scler. 2014; 20: 1207-1216.
  10. Fraser JA, Newman NJ, Biousse V. Disorders of the optic tract, radiation, and occipital lobe. Handb Clin Neurol. 2011; 102: 205-221.
  11. Ogawa K, Ishikawa H, Suzuki Y, Oishi M, Kamei S. Clinical study of the visual field defects caused by occipital lobe lesions. Cerebrovasc Dis. 2014; 37: 102-108.
  12. McDonald CR, Hagler DJ Jr, Girard HM, Pung C, Ahmadi ME, Holland D, et al. Changes in fiber tract integrity and visual fields after anterior temporal lobectomy. Neurology. 2010; 75: 1631-1638.
  13. Piper RJ, Yoong MM, Kandasamy J, Chin RF. Application of diffusion tensor imaging and tractography of the optic radiation in anterior temporal lobe resection for epilepsy: a systematic review. Clin Neurol Neurosurg. 2014; 124: 59-65.
  14. Romero RS, Gutierrez I, Wang E, Reder AT, Bhatti MT, Bernard JT, et al. Homonymous hemimacular thinning: a unique presentation of optic tract injury in neuromyelitis optica. J Neuroophthalmol. 2012; 32: 150-153.
  15. Huang-Link YM, Al-Hawasi A, Eveman I. Retrograde degeneration of visual pathway: hemimacular thinning of retinal ganglion cell layer in progressive and active multiple sclerosis. J Neurol. 2014; 261: 2453-2456.
  16. Huang-Link YM, Al-Hawasi A, Lindehammar H. Acute optic neuritis: retinal ganglion cell loss precedes retinal nerve fiber thinning. Neurol Sci. 2014.

 

 

 

Huang-Link YM, Petré B, Lindehammar H, Al-Hawasi A, Link H (2015) Homonymous Hemimacular Ganglion Cell Layer Loss Detectable by SD-OCT: A Biomarker of Retrochiasmal Visual Pathway Lesion. JSM Biomar 2(1): 1006

Received : 11 Jan 2015
Accepted : 04 Feb 2015
Published : 05 Feb 2015
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X